Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of GBP 1.38 billion. The enterprise value is 1.66 billion.

Market Cap	1.38B
Enterprise Value	1.66B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.23%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	161.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.81, with an EV/FCF ratio of 6.71.

EV / Earnings	-2.27
EV / Sales	0.79
EV / EBITDA	25.81
EV / EBIT	n/a
EV / FCF	6.71

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 1.05.

Current Ratio	1.73
Quick Ratio	1.58
Debt / Equity	1.05
Debt / EBITDA	20.05
Debt / FCF	4.79
Interest Coverage	-8.74

Financial Efficiency

Return on equity (ROE) is -51.65% and return on invested capital (ROIC) is -3.52%.

Return on Equity (ROE)	-51.65%
Return on Assets (ROA)	-3.13%
Return on Capital (ROIC)	-3.52%
Revenue Per Employee	370,988
Profits Per Employee	-140,642
Employee Count	5,600
Asset Turnover	0.66
Inventory Turnover	20.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.15% in the last 52 weeks. The beta is 1.10, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-52.15%
50-Day Moving Average	9.99
200-Day Moving Average	9.90
Relative Strength Index (RSI)	52.60
Average Volume (20 Days)	19,932

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.43

Income Statement

In the last 12 months, Teladoc Health had revenue of GBP 1.93 billion and -732.47 million in losses. Loss per share was -4.34.

Revenue	1.93B
Gross Profit	1.37B
Operating Income	-146.65M
Pretax Income	-724.36M
Net Income	-732.47M
EBITDA	49.38M
EBIT	-146.65M
Loss Per Share	-4.34

Full Income Statement

Balance Sheet

The company has 928.05 million in cash and 1.19 billion in debt, giving a net cash position of -257.41 million.

Cash & Cash Equivalents	928.05M
Total Debt	1.19B
Net Cash	-257.41M
Net Cash Per Share	n/a
Equity (Book Value)	1.12B
Book Value Per Share	6.54
Working Capital	505.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 252.08 million and capital expenditures -4.52 million, giving a free cash flow of 247.55 million.

Operating Cash Flow	252.08M
Capital Expenditures	-4.52M
Free Cash Flow	247.55M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.82%, with operating and profit margins of -7.59% and -37.91%.

Gross Margin	70.82%
Operating Margin	-7.59%
Pretax Margin	-37.49%
Profit Margin	-37.91%
EBITDA Margin	2.56%
EBIT Margin	-7.59%
FCF Margin	12.81%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.23%
Shareholder Yield	-3.23%
Earnings Yield	-53.03%
FCF Yield	17.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -4.93. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.93
Piotroski F-Score	n/a